Heterotropic allosteric effectors

Physiological benefits of cooperativity and heterotropic allosteric effectors. ... 

Figure 6 [70,80], This spectrum—which by decomposition analysis contains 70% as-nitrosyl hemes—is typical of a-subunit nitrosyl-Hb spectra obtained at neutral pH, and without additional T-state inducing heterotropic allosteric effectors [46],...

The separation between allosteric effectors and cooperativity lies in the molecule doing the affecting. If the effector molecule acts at another site and the effector is not the substrate, the effect is deemed allosteric and heterotropic. If the effector molecule is the substrate itself, the effect is called cooperative and/or homotropic. 

ALLOSTERIC EFFECTORS bind specifically to either the T or the R states. Heterotropic (nonsubstrate) activators bind to and stabilize the R state, while heterotropic inhibitors bind preferentially to the T state. 

Metabolic activators and inhibitors are structurally dissimilar to substrates. These effectors exert regulatory control over catalysis by binding at an allosteric site quite distinct from the catalytic site. Such heterotropic interactions are mediated through conformational changes, often involving subunit interactions. Allosteric effectors can alter the catalytic rate by changing the apparent substrate affinity (K system) or by altering the... 

Many proteins are regulated by molecules which bind somewhere other than at the active site and either inerease or decrease protein activity. These allosteric ejfectors are often quite specific and may have either a positive or negative effect upon protein activity. C ass cdX feedback inhibition cycles in metabolism generally involve heterotropic allostery, in which a molecule produced near the end of a metabolic pathway acts as an allosteric effector to regulate a protein active earlier in the same pathway. Because of the need for very precise control of the energy charge of the cell, ATP and ADP serve as allosteric effectors for several of the proteins of glucose metabolism. Protons and ions act as allosteric effectors in many... 

Homotropic effect refers to allosteric effects produced by enzyme s own substrate and heterotropic effects are due to metabohtes that are not stmcturaUy related to enzyme s substrates. Positive effects are related to enzyme activation and negative effects to enzyme inhibition. Thus, fmctose-diphosphate is a positive allosteric effector of pymvate kinase. 

An allosteric situation where is constant but the apparent changes in response to effectors is termed a V system. In a V system, all v versus S plots are hyperbolic rather than sigmoid (Figure 15.12). The positive heterotropic effector A activates by raising whereas 1, the negative heterotropic effec-... 

The architecture of various CYPs may accommodate entities of different shapes [139]. Several CYPs, particularly CYP3A4 [140,141] and CYP2C9 [142], may exhibit atypical (non-Michaelis-Menten) kinetics such as heterotropic activation, homotropic activation, substrate inhibition and partial inhibition, all in a substrate-effector-dependent manner [143]. Several hypotheses have been proposed to account for the observation of atypical kinetics, including simultaneous occupancy of the CYP active site by two substrates (or one substrate and one effector simultaneously) [144] and allosteric changes in CYP architecture due to binding of an effector [145,146]. Along... 

Heterotropic effectors The effector may be different from the substrate, in which case the effect is said to be heterotropic. For example, consider the feedback inhibition shown in Figure 5.17. The enzyme that converts A to B has an allosteric site that binds the end-product, E. If the concentration of E increases (for example, because it is not used as rapidly as it is synthesized), the initial enzyme in the pathway is inhibited. Feedback inhibition provides the cell with a product it needs by regulating the flow of substrate molecules through the pathway that synthesizes that product. [Note Heterotropic effectors are commonly encountered, for example, the glycolytic enzyme phosphofructokinases allosterically inhibited by citrate, which is not a substrate for the enzyme (see p. 97).]... 

Fig. 9-10 Behavior of an MWC allosteric enzyme in the presence of positive and negative heterotropic effectors. The activator term, y, in Eq. (9.62) causes the curve to become more hyperbolic, whereas the inhibitor term (j3) renders it more sigmoidal. The curves were constructed using Eq. (9.62) with L = 1,000 and n - 4.

The product of this reaction, oxaloacetate, can either enter the gluconeogenic pathway (Chap. 11) by way of malate or condense with acetyl-CoA to yield citrate. Pyruvate carboxylase is an allosteric enzyme, and it is activated by the heterotropic effector, acetyl-CoA. Thus, pyruvate in the mitochondria is the substrate for either pyruvate dehydrogenase or pyruvate carboxylase, the activities of which, in turn, are controlled by reactants associated with the citric acid cycle. The interplay among pyruvate dehydrogenase, pyruvate carboxylase, pyruvate, and the citric acid cycle is shown in Fig. 12-9. 

Unlike the midpoint slope (//1/2) of an ideal Nernstian plot, the slope of a non-Nernstian response cannot be interpreted as the number of electrons involved in the oxidation/reduction process. For the Hbs, the n parameter is influenced by site-site heterogeneity and allosteric effects.The n parameter is an indicator of the level of cooperativity that is operative high n values indicate a high level of cooperativity, while low n values indicate reduced cooperativity. The sensitivity of the n parameter to heterotropic effectors may be seen in Figure 2.11. The trend illustrated is consistent with the two-state (R and T) model for Hb. Maximum cooperativity is indicated by the highest values for max (defined in Figure 2.4) as illustrated for Hb o the absence of a heterotropic effector. The T-state is stabilised by heterotropic effectors (data points 1-4), which results in an increase in ease of reduction (increase in 1/2) and a decrease in cooperativity (decrease in max) due to a diminished ease of T R shift as a result of T-state stabilisation. R-state stabilisation occurs in HbCPA and horse Hb (data points 6-9), which is characterised by an increase in ease of oxidation (lower Eijf) and reduced cooperativity as illustrated by diminished max values. 

---